APTUS Biotech

CAT-ApMnkQ2

Biodrugs/ Drugs

Aptusbiotech intend to develop novel therapies against Anaplastic Thyroid Cancer (CAT) based on our aptamer apMNKQ2 improving its design and applying updated formulations
1Non Regulatory Preclinical